![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ERRATUM article
Front. Immunol. , 23 March 2023
Sec. Cancer Immunity and Immunotherapy
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1185185
This article is an erratum on:
Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer
An Erratum on
Overcoming immune resistance with radiation therapy in prostate cancer
by Mulvey A, Muggeo-Bertin E, Berthold DR and Herrera FG (2022) Front. Immunol. 13:859785. doi: 10.3389/fimmu.2022.859785
An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Lausanne”.
The original version of this article has been updated.
Keywords: prostate cancer, radiation therapy, immunotherapy, immune checkpoint inhibitors, tumor micro-environment, cold tumor, abscopal effect
Citation: Frontiers Production Office (2023) Erratum: Overcoming immune resistance with radiation therapy in prostate cancer. Front. Immunol. 14:1185185. doi: 10.3389/fimmu.2023.1185185
Received: 13 March 2023; Accepted: 13 March 2023;
Published: 23 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.